Imperva Inc (IMPV) Expected to Post Earnings of $0.13 Per Share

Brokerages expect Imperva Inc (NASDAQ:IMPV) to report earnings of $0.13 per share for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Imperva’s earnings. The lowest EPS estimate is $0.10 and the highest is $0.24. Imperva posted earnings of $0.40 per share in the same quarter last year, which would indicate a negative year over year growth rate of 67.5%. The firm is expected to issue its next quarterly earnings results on Thursday, February 14th.

On average, analysts expect that Imperva will report full year earnings of $0.32 per share for the current fiscal year, with EPS estimates ranging from $0.22 to $0.49. For the next year, analysts expect that the company will report earnings of $0.94 per share, with EPS estimates ranging from $0.79 to $1.09. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that cover Imperva.

Imperva (NASDAQ:IMPV) last issued its quarterly earnings results on Wednesday, October 31st. The software maker reported $0.43 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.18 by $0.25. Imperva had a negative net margin of 8.00% and a negative return on equity of 5.62%. The company had revenue of $91.63 million for the quarter, compared to the consensus estimate of $89.24 million.

IMPV has been the topic of a number of analyst reports. Royal Bank of Canada reaffirmed a “buy” rating and set a $62.00 price objective on shares of Imperva in a research note on Friday, July 27th. Evercore ISI reaffirmed a “buy” rating and set a $56.00 price objective on shares of Imperva in a research note on Friday, July 27th. UBS Group cut shares of Imperva from an “outperform” rating to a “market perform” rating in a research note on Friday, July 27th. DA Davidson cut shares of Imperva from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $56.00 to $46.00 in a research note on Friday, July 27th. Finally, Oppenheimer cut shares of Imperva from an “outperform” rating to a “market perform” rating and set a $70.00 price objective on the stock. in a research note on Friday, July 27th. Ten analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. Imperva currently has an average rating of “Hold” and an average target price of $56.37.

A number of institutional investors have recently added to or reduced their stakes in the stock. Royal Bank of Canada grew its stake in Imperva by 99.4% in the 1st quarter. Royal Bank of Canada now owns 2,794 shares of the software maker’s stock valued at $122,000 after acquiring an additional 1,393 shares during the period. Public Employees Retirement Association of Colorado grew its stake in Imperva by 142.6% in the 3rd quarter. Public Employees Retirement Association of Colorado now owns 2,608 shares of the software maker’s stock valued at $121,000 after acquiring an additional 1,533 shares during the period. Xact Kapitalforvaltning AB grew its stake in Imperva by 38.0% in the 2nd quarter. Xact Kapitalforvaltning AB now owns 6,537 shares of the software maker’s stock valued at $315,000 after acquiring an additional 1,800 shares during the period. Russell Investments Group Ltd. grew its stake in Imperva by 276.2% in the 1st quarter. Russell Investments Group Ltd. now owns 2,588 shares of the software maker’s stock valued at $112,000 after acquiring an additional 1,900 shares during the period. Finally, Summit Global Investments grew its stake in Imperva by 14.2% in the 3rd quarter. Summit Global Investments now owns 15,300 shares of the software maker’s stock valued at $711,000 after acquiring an additional 1,900 shares during the period. 94.41% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NASDAQ IMPV traded down $0.04 during midday trading on Thursday, reaching $55.81. 453,271 shares of the stock were exchanged, compared to its average volume of 939,638. The stock has a market capitalization of $1.97 billion, a price-to-earnings ratio of -199.32 and a beta of 1.35. Imperva has a twelve month low of $37.17 and a twelve month high of $57.65.

Imperva Company Profile

Imperva, Inc engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments.

Read More: Understanding each part of a balance sheet

Get a free copy of the Zacks research report on Imperva (IMPV)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply